122 related articles for article (PubMed ID: 37190861)
1. Distinct subunit architecture and assembly pattern of DNA gyrase from mycobacteria.
Faheem I; Gupta R; Nagaraja V
Mol Microbiol; 2023 Jun; 119(6):728-738. PubMed ID: 37190861
[TBL] [Abstract][Full Text] [Related]
2. Functional interactions between gyrase subunits are optimized in a species-specific manner.
Weidlich D; Klostermeier D
J Biol Chem; 2020 Feb; 295(8):2299-2312. PubMed ID: 31953321
[TBL] [Abstract][Full Text] [Related]
3. Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity.
Aubry A; Pan XS; Fisher LM; Jarlier V; Cambau E
Antimicrob Agents Chemother; 2004 Apr; 48(4):1281-8. PubMed ID: 15047530
[TBL] [Abstract][Full Text] [Related]
4. Mycobacterium tuberculosis DNA gyrase possesses two functional GyrA-boxes.
Bouige A; Darmon A; Piton J; Roue M; Petrella S; Capton E; Forterre P; Aubry A; Mayer C
Biochem J; 2013 Nov; 455(3):285-94. PubMed ID: 23869946
[TBL] [Abstract][Full Text] [Related]
5. Fluoroquinolone-gyrase-DNA complexes: two modes of drug binding.
Mustaev A; Malik M; Zhao X; Kurepina N; Luan G; Oppegard LM; Hiasa H; Marks KR; Kerns RJ; Berger JM; Drlica K
J Biol Chem; 2014 May; 289(18):12300-12. PubMed ID: 24497635
[TBL] [Abstract][Full Text] [Related]
6. Discoordinate gene expression of gyrA and gyrB in response to DNA gyrase inhibition in Escherichia coli.
Neumann S; Quiñones A
J Basic Microbiol; 1997; 37(1):53-69. PubMed ID: 9090126
[TBL] [Abstract][Full Text] [Related]
7. The acidic C-terminal tail of the GyrA subunit moderates the DNA supercoiling activity of Bacillus subtilis gyrase.
Lanz MA; Farhat M; Klostermeier D
J Biol Chem; 2014 May; 289(18):12275-85. PubMed ID: 24563461
[TBL] [Abstract][Full Text] [Related]
8. The key DNA-binding residues in the C-terminal domain of Mycobacterium tuberculosis DNA gyrase A subunit (GyrA).
Huang YY; Deng JY; Gu J; Zhang ZP; Maxwell A; Bi LJ; Chen YY; Zhou YF; Yu ZN; Zhang XE
Nucleic Acids Res; 2006; 34(19):5650-9. PubMed ID: 17038336
[TBL] [Abstract][Full Text] [Related]
9. Sequence analysis, purification, and study of inhibition by 4-quinolones of the DNA gyrase from Mycobacterium smegmatis.
Revel-Viravau V; Truong QC; Moreau N; Jarlier V; Sougakoff W
Antimicrob Agents Chemother; 1996 Sep; 40(9):2054-61. PubMed ID: 8878580
[TBL] [Abstract][Full Text] [Related]
10. Functional characterisation of mycobacterial DNA gyrase: an efficient decatenase.
Manjunatha UH; Dalal M; Chatterji M; Radha DR; Visweswariah SS; Nagaraja V
Nucleic Acids Res; 2002 May; 30(10):2144-53. PubMed ID: 12000834
[TBL] [Abstract][Full Text] [Related]
11. A monoclonal antibody that inhibits mycobacterial DNA gyrase by a novel mechanism.
Manjunatha UH; Maxwell A; Nagaraja V
Nucleic Acids Res; 2005; 33(10):3085-94. PubMed ID: 15930158
[TBL] [Abstract][Full Text] [Related]
12. Consequences of producing DNA gyrase from a synthetic gyrBA operon in Salmonella enterica serovar Typhimurium.
Pozdeev G; Mogre A; Dorman CJ
Mol Microbiol; 2021 Jun; 115(6):1410-1429. PubMed ID: 33539568
[TBL] [Abstract][Full Text] [Related]
13. An orphan gyrB in the Mycobacterium smegmatis genome uncovered by comparative genomics.
Jain P; Nagaraja V
J Genet; 2002 Dec; 81(3):105-10. PubMed ID: 12717039
[TBL] [Abstract][Full Text] [Related]
14. Rewired Downregulation of DNA Gyrase Impacts Cell Division, Expression of Topology Modulators, and Transcription in Mycobacterium smegmatis.
Guha S; Udupa S; Ahmed W; Nagaraja V
J Mol Biol; 2018 Dec; 430(24):4986-5001. PubMed ID: 30316784
[TBL] [Abstract][Full Text] [Related]
15. Impact of the E540V amino acid substitution in GyrB of Mycobacterium tuberculosis on quinolone resistance.
Kim H; Nakajima C; Yokoyama K; Rahim Z; Kim YU; Oguri H; Suzuki Y
Antimicrob Agents Chemother; 2011 Aug; 55(8):3661-7. PubMed ID: 21646485
[TBL] [Abstract][Full Text] [Related]
16. Double mutation in DNA gyrase confers moxifloxacin resistance and decreased fitness of Mycobacterium smegmatis.
Luo T; Yuan J; Peng X; Yang G; Mi Y; Sun C; Wang C; Zhang C; Bao L
J Antimicrob Chemother; 2017 Jul; 72(7):1893-1900. PubMed ID: 28387828
[TBL] [Abstract][Full Text] [Related]
17. The role of Ca²⁺ in the activity of Mycobacterium tuberculosis DNA gyrase.
Karkare S; Yousafzai F; Mitchenall LA; Maxwell A
Nucleic Acids Res; 2012 Oct; 40(19):9774-87. PubMed ID: 22844097
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies to mycobacterial DNA gyrase A inhibit DNA supercoiling activity.
Manjunatha UH; Mahadevan S; Visweswariah SS; Nagaraja V
Eur J Biochem; 2001 Apr; 268(7):2038-46. PubMed ID: 11277926
[TBL] [Abstract][Full Text] [Related]
19. DNA gyrase inhibition assays are necessary to demonstrate fluoroquinolone resistance secondary to gyrB mutations in Mycobacterium tuberculosis.
Pantel A; Petrella S; Matrat S; Brossier F; Bastian S; Reitter D; Jarlier V; Mayer C; Aubry A
Antimicrob Agents Chemother; 2011 Oct; 55(10):4524-9. PubMed ID: 21768507
[TBL] [Abstract][Full Text] [Related]
20. Novel gyrase mutations in quinolone-resistant and -hypersusceptible clinical isolates of Mycobacterium tuberculosis: functional analysis of mutant enzymes.
Aubry A; Veziris N; Cambau E; Truffot-Pernot C; Jarlier V; Fisher LM
Antimicrob Agents Chemother; 2006 Jan; 50(1):104-12. PubMed ID: 16377674
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
